President Donald Trump plans to impose a 100% tariff on pharmaceuticals imported into the U.S., unless firms build a manufacturing presence in the country. The European Union and Japan are exempt from this tariff due to previously negotiated trade deals. However, Britain, which has a pending trade deal with the U.S., is not exempt.